Generic competition and price developments in the USA, Germany and Switzerland (2007-2023): a longitudinal observational study.

ABSTRACT:

Introduction

Drug expenditure has increased over the past years in the USA and Europe, mainly driven by originator drugs. Generic drugs have a substantial cost-saving potential. We analysed the number of generic competitors entering the market over time, distribution of market share between originator drugs and their generic competitors and association between the number of generic competitors and price changes of originator and generic drugs in the USA, Germany and Switzerland.

Methods

In this longitudinal observational study, we included all originator drugs and their corresponding generic competitors with market entry between 2007 and 2023 in the USA, Germany and Switzerland from the IQVIA database. We extracted quarterly price and sales volume data for the same study per

SUBMITTER: Hediger S 

PROVIDER: S-EPMC12458845 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature